Danimer Scientific Inc
NYSE:DNMR
Intrinsic Value
Danimer Scientific, Inc. operates as a next generation bioplastics company. [ Read More ]
The intrinsic value of one DNMR stock under the Base Case scenario is 3.7665 USD. Compared to the current market price of 0.8074 USD, Danimer Scientific Inc is Undervalued by 79%.
Valuation Backtest
Danimer Scientific Inc
Run backtest to discover the historical profit from buying and selling DNMR stocks based on their intrinsic value.
Analyze the historical link between intrinsic value and market price to make more informed investment decisions.
Fundamental Analysis
Balance Sheet Decomposition
Danimer Scientific Inc
Current Assets | 108m |
Cash & Short-Term Investments | 59.2m |
Receivables | 18.9m |
Other Current Assets | 30m |
Non-Current Assets | 590.1m |
PP&E | 464.3m |
Intangibles | 77.8m |
Other Non-Current Assets | 48m |
Current Liabilities | 15.7m |
Accounts Payable | 5.3m |
Accrued Liabilities | 7.5m |
Other Current Liabilities | 2.9m |
Non-Current Liabilities | 404.4m |
Long-Term Debt | 381.4m |
Other Non-Current Liabilities | 23m |
Earnings Waterfall
Danimer Scientific Inc
Revenue
|
46.7m
USD
|
Cost of Revenue
|
-71m
USD
|
Gross Profit
|
-24.3m
USD
|
Operating Expenses
|
-100.9m
USD
|
Operating Income
|
-125.2m
USD
|
Other Expenses
|
-30.3m
USD
|
Net Income
|
-155.5m
USD
|
Free Cash Flow Analysis
Danimer Scientific Inc
DNMR Profitability Score
Profitability Due Diligence
Danimer Scientific Inc's profitability score is 20/100. The higher the profitability score, the more profitable the company is.
Score
Danimer Scientific Inc's profitability score is 20/100. The higher the profitability score, the more profitable the company is.
DNMR Solvency Score
Solvency Due Diligence
Danimer Scientific Inc's solvency score is 31/100. The higher the solvency score, the more solvent the company is.
Score
Danimer Scientific Inc's solvency score is 31/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
DNMR Price Targets Summary
Danimer Scientific Inc
According to Wall Street analysts, the average 1-year price target for DNMR is 1.6014 USD with a low forecast of 1.01 USD and a high forecast of 2.1 USD.
Ownership
DNMR Insider Trading
Buy and sell transactions by insiders
Period | Sold | Bought | Net |
---|---|---|---|
3 Months |
|
|
|
6 Months |
|
|
|
9 Months |
|
|
|
12 Months |
|
|
|
Shareholder Return
DNMR Price
Danimer Scientific Inc
Average Annual Return | -2.64% |
Standard Deviation of Annual Returns | 117.19% |
Max Drawdown | -99% |
Market Capitalization | 92.2m USD |
Shares Outstanding | 114 240 000 |
Percentage of Shares Shorted | 20.51% |
Company Profile
Country
Industry
Market Cap
Dividend Yield
Description
Danimer Scientific, Inc. operates as a next generation bioplastics company. The company is headquartered in Bainbridge, Georgia and currently employs 282 full-time employees. The company went IPO on 2020-05-06. The firm primarily market its products to consumer packaging brand owners, converters and manufacturers in the plastics industry. Its technology includes PHA Technology platform and PLA Technology Platform. The firm is a producer of polyhydroxyalkanoate (PHA), which serve as a biodegradable alternative to petrochemical-based plastics. The company also creates plastics using the natural plastic polylactic acid (PLA) as a base resin. The Company’s products include PHA-based resins and PLA-based resins. Its PHA-based resins are produced through fermentation process where bacteria consume vegetable oil and produce PHA as energy reserves. The company sells PHA under Nodax brand in a variety of plastic applications. Its PLA-based resins are made from dextrose sugar that is derived from corn, sugar beets and sugar cane,
Contact
IPO
Employees
Officers
The intrinsic value of one DNMR stock under the Base Case scenario is 3.7665 USD.
Compared to the current market price of 0.8074 USD, Danimer Scientific Inc is Undervalued by 79%.